Rani Therapeutics

RANINasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$108.436 M

$0.78 -1.46%

Close of 22 Sept 2026

Revenue

$1.63M

#3439 by revenue

Earnings

-$29.7M

Loss-making

Shares outstanding

—

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#304Tiziana Life SciencesTLSA$113.2M
#305Quantum CyberQUCY$111.0M
#306Rani TherapeuticsRANI$108.4M
#307Polaryx TherapeuticsPLYX$107.2M
#308RafaelRFL$104.0M

What if Rani Therapeutics were worth as much as…

Open the what-if tool →

Gold $30.2T

$216,893.72

Per share 278,820× higher

Bitcoin $1.74T

$12,494.36

Per share 16,062× higher

Nvidia $5.52T

$39,569.24

Per share 50,867× higher

Or at a round number

$200.0M $500.0M $1.00B $2.00B

Where these numbers come from

Share counts and financials for Rani Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.